Literature DB >> 28633901

Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.

Isano Hase1, Kozo Morimoto2, Takuro Sakagami3, Yoshiki Ishii4, Jakko van Ingen5.   

Abstract

Nontuberculous mycobacteria (NTM) infections involving anti-interferon-gamma (IFN-γ)-neutralizing autoantibodies have been described in previously immunocompetent adults. To investigate the factors underlying various disease manifestations, we reviewed 35 articles published between January 2004 and November 2016 and identified 111 NTM patients with anti-IFN-γ autoantibodies. Rapidly growing mycobacteria (RGM) accounted for 53% of the isolated species. RGM were predominant among the NTM species isolated from Thai (73%), Chinese (58%) and Filipino (56%) patients, whereas M. avium complex (MAC) was predominant among Japanese (58%) and non-Asian (80%) patients. The commonly involved organs included the lymph nodes (79%), bones/joints (34%) and lungs (32%). Compared with the patients with MAC, the patients with RGM had a higher incidence of lymph node lesions (P<0.05) and a lower incidence of bone/joint (P<0.01), lung (P<0.01), soft tissue (P<0.01), bronchus (P<0.01) and muscle (P<0.05) lesions. Clinical manifestations of NTM disease with anti-IFN-γ-neutralizing autoantibodies differ across ethnicities and NTM species.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult-onset immunodeficiency; Anti-interferon-gamma autoantibody; Clinical manifestation; Ethnicity; Nontuberculous mycobacterium

Mesh:

Substances:

Year:  2017        PMID: 28633901     DOI: 10.1016/j.diagmicrobio.2017.05.011

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  12 in total

1.  Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.

Authors:  Gloria H Hong; Ana M Ortega-Villa; Sally Hunsberger; Ploenchan Chetchotisakd; Siriluck Anunnatsiri; Piroon Mootsikapun; Lindsey B Rosen; Christa S Zerbe; Steven M Holland
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

2.  Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.

Authors:  Kazutaka Yoshizawa; Ami Aoki; Kenjiro Shima; Yoshinari Tanabe; Toshiyuki Koya; Takashi Hasegawa; Toshiaki Kikuchi; Takuro Sakagami
Journal:  J Clin Immunol       Date:  2020-02-07       Impact factor: 8.317

Review 3.  Minireview: Insights into anti-interferon-γ autoantibodies.

Authors:  Kriangkrai Chawansuntati; Kritsadee Rattanathammethee; Jiraprapa Wipasa
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-11

Review 4.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

5.  Anticytokine autoantibodies leading to infection: early recognition, diagnosis and treatment options.

Authors:  Gabriela Barcenas-Morales; Paulina Cortes-Acevedo; Rainer Doffinger
Journal:  Curr Opin Infect Dis       Date:  2019-08       Impact factor: 4.915

6.  Evaluation of plasma anti-GPL-core IgA and IgG for diagnosis of disseminated non-tuberculous mycobacteria infection.

Authors:  Arnone Nithichanon; Waraporn Samer; Ploenchan Chetchotisakd; Chidchamai Kewcharoenwong; Manabu Ato; Ganjana Lertmemongkolchai
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

Review 7.  Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.

Authors:  Long-Fang Chen; Cheng-De Yang; Xiao-Bing Cheng
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

8.  Treatment Dilemmas in Disseminated Nontuberculous Mycobacterial Infections With Interferon-gamma Autoantibodies.

Authors:  Elizabeth M King; Victoria K Weaver; Mary H Kestler
Journal:  Open Forum Infect Dis       Date:  2021-06-23       Impact factor: 3.835

9.  Characterization of Anti-Interferon-γ Antibodies in HIV-Negative Patients Infected With Disseminated Talaromyces marneffei and Cryptococcosis.

Authors:  Wen Zeng; Ye Qiu; Shudan Tang; Jianquan Zhang; Mianluan Pan; Xiaoning Zhong
Journal:  Open Forum Infect Dis       Date:  2019-10-11       Impact factor: 3.835

10.  Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies.

Authors:  Wannada Laisuan; Prapaporn Pisitkun; Pintip Ngamjanyaporn; Thanitta Suangtamai; Porpon Rotjanapan
Journal:  Open Forum Infect Dis       Date:  2020-01-31       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.